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due to impairing of the phenotypic plasticity that causes 
cells to adopt stem cell and pro-migratory characteristics. 
Further mechanistic studies are focusing on alterations to 
stem cell subpopulations after radiation and superadded 
notch inhibition. 
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Purpose or Objective  
Fanconi anaemia (FA) is an autosomal recessive disorder 
characterised by defects in DNA repair associated with 
chromosomal instability. FA cells exhibit cellular 
hypersensitivity to DNA cross-linking agents such as 
mitomycin C (MMC). The clinical manifestations include 
congenital and developmental abnormalities and 
haematological defects. It has previously been shown that 
FA patients undergoing radiotherapy display increased 
clinical radiosensitivity by exhibiting adverse normal 
tissues side-effects. Evidence suggests that FA patients 
are chromosomally radiosensitive to ionising radiation, 
however, with very limited data.  
The aim of this study is to investigate chr omosomal 
radiosensitivity and genomic instability of hom ozygous 
and heterozygous carriers of FA mutations compared to 
healthy individuals using the micronucleus (MN) assays. 
Material and Methods  
For the G0 MN assay, heparinised blood in culture medium 
was irradiated at 0Gy (Baseline), 2Gy and 4Gy followed by 
the immediate stimulation of lymphocytes using 
phytohaemagglutinin (PHA). Cytochalasin B was added 23 
hours later to inhibit cytoplasmic division. Cells were 
harvested 70 hours post irradiation. 
The S/G2 MN assay is a modified version of the G0 MN 
assay. To initiate the assay, the cultures are stimulated 
with PHA and then irradiated with the same radiation 
doses 72 hours after stimulation. To detect DNA damage 
in the S/G2 phase of the cell cycle, the cells were 
harvested 8 hours post irradiation.  
The third assay is similar to the G0 MN assay except the 
cell damage is induced using MMC. 
Subsequent to harvest, all slides were prepared and 
stained with acridine orange and micronuclei were scored 
using a fluorescent microscope.  
Results  
When compared to parents and healthy controls, 
spontaneously occurring micronuclei are significantly 
higher in FA patients indicating genomic instability. A 
similar trend is noticed in the micronuclei frequency of 
irradiated FA cells signifying chromosomal 
radiosensitivity. This sensitivity is evidently pronounced in 
the S/G2 phase. Elevated chromosomal damage was also 
detected with MMC treatment in the FA patients. 
Conclusion  
Chromosomal radiosensitivity and genomic instability of 
FA mutation carriers are notably higher when compared to 
healthy individuals.  
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Purpose or Objective  
External beam radiotherapy (EBRT) treats gross tumors 
and local microscopic diseases. Radionuclide therapy by 
isotopes can control tumors systemically. Rhenium 188 
(188Re)-liposome, a nanoparticle undergoing clinical trials, 
emits gamma rays for imaging validation and beta rays for 
therapy with biodistribution profiles preferential to 
tumors. We designed a unique combinatory treatment and 
examined its effects on lung metastasis from esophageal 
cancer, a malignancy with poor prognosis.  
Material and Methods  
Human esophageal cancer BE-3 cells with luciferase gene 
for optical imaging were injected into tail vein of nude 
mice to induce lung metastasis. The radiochemical purity 
of 188Re-liposome exceeded 95%. Molecular imaging by 
NanoSPECT/CT (NanoSPECT/CT PLUS, Mediso, 
Alsotorokvesz, Budapest, Hungary) showed that lung 
metastatic lesion could uptake the 188Re-liposome. For 
biodistribution, the radioactivity of 188Re-liposome was 
detected by Auto-Gamma counter (Packard Cobra II, 
Canberra, Germany), and the uptake of 188Re-liposome in 
each organ was expressed as the percentage of injected 
dose per gram of tissue (% ID/g). Low-dose whole lung 
EBRT with 3 consecutive daily fractions of 1 Gy was 
delivered by linear accelerator with 6-MV photon (Clinac 
iX, Varian Medical Systems, USA) followed by intravenous 
188Re-liposome (250 µCi) administration 2-h after last 
teletherapy. Flow cytometry was used to estimate the 
amount of myeloid derived suppressor cells and 
macrophages. 
Results  
The combination of EBRT and 188Re-liposome inhibited 
tumor burden of lung metastasis faster and better than 
each treatment alone (Figure 1 and 2). Combination 
treatment did no cause additive adverse effects on white 
blood cell counts, body weight, or liver and renal 
functions. EBRT significantly reduced the uptake of 188Re-
liposome in lung, kidney, bone marrow and blood. In 
spleen, 188Re-liposome administration declined the 
amount of myeloid derived suppressor cells and increased 
the amount of M1 and M2 macrophages. 
 
 
Figure 1. The therapeutic efficacy of 188Re-liposome 
